Newman Michael James bought INDP
December 22, 2025 · Form 4 insider transaction
Newman Michael James bought 52,204 shares of Indaptus Therapeutics, Inc. at $2.03 per share, a transaction worth $106.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
52,204
Price
$2.03
Total value
$106.0K
InsiderNewman Michael James
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 22, 2025
Filing dateDecember 29, 2025
Shares owned after101,074
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person acquired 52,204 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025.